Company Registration Number 10839581 (England and Wales)
RX PARTNERS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2025
PAGES FOR FILING WITH REGISTRAR
TWP Accounting LLP
Chartered Accountants
The Old Rectory
Church Street
Weybridge
Surrey
KT13 8DE
RX PARTNERS LIMITED
Company Registration No. 10839581
BALANCE SHEET
- 1 -
2025
2024
£
£
£
£
Fixed assets
31,049
35,548
Current assets
44,567
49,130
Creditors: amounts falling due within one year
(2,553,014)
(2,639,068)
Net current liabilities
(2,508,447)
(2,589,938)
Total assets less current liabilities
(2,477,398)
(2,554,390)
Creditors: amounts falling due after more than one year
(15,461)
Net liabilities
(2,477,398)
(2,569,851)
Capital and reserves
(2,477,398)
(2,569,851)
Notes to the financial statements
1
Employees
The average number of persons, including directors, employed by the company during the year was as follows:
2025
2024
Number
Number
Employees
2
3
RX Partners Limited is a private company limited by shares incorporated in England and Wales. The registered office is 4th Floor 35 Dover Street, Mayfair, London, United Kingdom,, W1S 4NQ.
For the year ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
RX PARTNERS LIMITED
Company Registration No. 10839581
BALANCE SHEET (CONTINUED)
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 23 June 2026
R Hatcher
Director